BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29956186)

  • 21. Mechanism(s) of FIV vaccine protection.
    Pu R; Tellier MC; Yamamoto JK
    Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.
    Giannecchini S; Isola P; Sichi O; Matteucci D; Pistello M; Zaccaro L; Del Mauro D; Bendinelli M
    J Virol; 2002 Jul; 76(14):6882-92. PubMed ID: 12072489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
    Coleman JK; Pu R; Martin MM; Noon-Song EN; Zwijnenberg R; Yamamoto JK
    Vaccine; 2014 Feb; 32(6):746-54. PubMed ID: 23800540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response.
    Bishop SA; Stokes CR; Gruffydd-Jones TJ; Whiting CV; Humphries JE; Osborne R; Papanastasopoulou M; Harbour DA
    Vaccine; 1996 Sep; 14(13):1243-50. PubMed ID: 8961513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
    Stickney A; Ghosh S; Cave NJ; Dunowska M
    Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.
    Matteucci D; Poli A; Mazzetti P; Sozzi S; Bonci F; Isola P; Zaccaro L; Giannecchini S; Calandrella M; Pistello M; Specter S; Bendinelli M
    J Virol; 2000 Dec; 74(23):10911-9. PubMed ID: 11069985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines.
    Tellier MC; Soos J; Pu R; Pollock D; Yamamoto JK
    Vet Microbiol; 1997 Jun; 57(1):1-11. PubMed ID: 9231977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
    Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
    Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dual-subtype vaccine against feline immunodeficiency virus infection.
    Hohdatsu T; Okada S; Motokawa K; Aizawa C; Yamamoto JK; Koyama H
    Vet Microbiol; 1997 Nov; 58(2-4):155-65. PubMed ID: 9453127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
    Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
    J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
    Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
    Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
    Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus.
    Tijhaar EJ; Huisman W; Huisman RC; Siebelink KH; Karlas JA; de Ronde A; van Herwijnen R; Mooi FR; Osterhaus AD
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3265-75. PubMed ID: 9400977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
    Yamamoto JK; Sanou MP; Abbott JR; Coleman JK
    Curr HIV Res; 2010 Jan; 8(1):14-25. PubMed ID: 20210778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic utility of CD4%:CD8 low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats.
    Litster A; Lin JM; Nichols J; Weng HY
    Vet Microbiol; 2014 Jun; 170(3-4):197-205. PubMed ID: 24559863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.